Chung Wu Investment Group LLC Has $574,000 Holdings in UnitedHealth Group Incorporated $UNH

Chung Wu Investment Group LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 71.4% in the 2nd quarter, Holdings Channel reports. The fund owned 1,840 shares of the healthcare conglomerate’s stock after selling 4,583 shares during the quarter. Chung Wu Investment Group LLC’s holdings in UnitedHealth Group were worth $574,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of UNH. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after purchasing an additional 196,696 shares during the last quarter. Nuveen LLC bought a new stake in UnitedHealth Group during the 1st quarter worth about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. increased its position in shares of UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after acquiring an additional 847,054 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of analyst reports. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Bank of America lifted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Truist Financial lifted their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Finally, Piper Sandler cut their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Trading Up 1.8%

UNH opened at $360.17 on Monday. The company has a 50-day simple moving average of $307.84 and a 200 day simple moving average of $353.45. The stock has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.